» Articles » PMID: 29976650

Dyspnoea in Patients Receiving Noninvasive Ventilation for Acute Respiratory Failure: Prevalence, Risk Factors and Prognostic Impact: A prospective Observational Study

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2018 Jul 7
PMID 29976650
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Dyspnoea is a frequent and intense symptom in intubated patients, but little attention has been paid to dyspnoea during noninvasive mechanical ventilation in the intensive care unit (ICU).The objectives of this study were to quantify the prevalence, intensity and prognostic impact of dyspnoea in patients receiving noninvasive ventilation (NIV) for acute respiratory failure (ARF) based on secondary analysis of a prospective observational cohort study in patients who received ventilatory support for ARF in 54 ICUs in France and Belgium. Dyspnoea was measured by a modified Borg scale.Among the 426 patients included, the median (interquartile range) dyspnoea score was 4 (3-5) on admission and 3 (2-4) after the first NIV session (p=0.001). Dyspnoea intensity ≥4 after the first NIV session was associated with the Sequential Organ Failure Assessment Score (odds ratio (OR) 1.12, p=0.001), respiratory rate (OR 1.03, p=0.032), anxiety (OR 1.92, p=0.006), leaks (OR 2.5, p=0.002) and arterial carbon dioxide tension (OR 0.98, p=0.025). Dyspnoea intensity ≥4 was independently associated with NIV failure (OR 2.41, p=0.001) and mortality (OR 2.11, p=0.009), but not with higher post-ICU burden and altered quality of life.Dyspnoea is frequent and intense in patients receiving NIV for ARF and is associated with a higher risk of NIV failure and poorer outcome.

Citing Articles

Response to "Relationships between dyspnea, oxygenation and prognosis in hypoxemic respiratory failure".

Demoule A, Baptiste A, Decavele M, Belin L, Frat J Crit Care. 2025; 29(1):90.

PMID: 40011945 PMC: 11866574. DOI: 10.1186/s13054-025-05280-3.


The occurrence mechanism, assessment, and non-pharmacological treatment of dyspnea.

Gao B, Wang S, Jiang S Med Rev (2021). 2024; 4(5):395-412.

PMID: 39444798 PMC: 11495473. DOI: 10.1515/mr-2024-0006.


Multimodal physiological correlates of dyspnea ratings during breath-holding in healthy humans.

Decavele M, Nierat M, Laviolette L, Wattiez N, Bachasson D, Kemoun G Eur J Appl Physiol. 2024; 125(3):729-737.

PMID: 39387934 DOI: 10.1007/s00421-024-05627-8.


Low dose of morphine to relieve dyspnea in acute respiratory failure: the OpiDys double-blind randomized controlled trial.

Deleris R, Bureau C, Lebbah S, Decavele M, Dres M, Mayaux J Respir Res. 2024; 25(1):280.

PMID: 39014448 PMC: 11251226. DOI: 10.1186/s12931-024-02867-2.


Breathlessness assessment, management and impact in the intensive care unit: a rapid review and narrative synthesis.

Richardson B, Decavele M, Demoule A, Murtagh F, Johnson M Ann Intensive Care. 2024; 14(1):107.

PMID: 38967813 PMC: 11229436. DOI: 10.1186/s13613-024-01338-7.